Ark Genomic Revolution ETF (ARKG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARKG | VHT | XBI | ||
| Company | Ark Genomic Revolution ETF | Healthcare ETF Vanguard | S&P Biotech SPDR | ||
| Price Information | |||||
| Exchange | NYSE Arca | NYSE Arca | NYSE Arca | ||
| Open | 26.29 | 270.08 | 123.24 | ||
| High | 26.31 | 270.42 | 123.69 | ||
| Low | 24.76 | 264.97 | 119.51 | ||
| Latest | 25.01 | 265.36 | 119.59 | ||
| Change | -1.50 | -5.06 | -4.31 | ||
| % Change | -5.66% | -1.87% | -3.48% | ||
| Volume | 4,214,400 | 180,100 | 10,706,300 | ||
| 20-Day Average Volume | 2,870,490 | 213,785 | 10,157,600 | ||
| Previous Close | 26.51 | 270.42 | 123.90 | ||
| Industry | N/A | N/A | Finance - Investment Funds | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 27.34 | 277.96 | 123.51 | ||
| 20-Day Raw Stochastic | 4.75% | 1.32% | 12.82% | ||
| 20-Day Relative Strength | 36.69 | 31.66 | 44.06 | ||
| Weighted Alpha | +5.45 | -0.12 | +40.95 | ||
| Today's Opinion | 56% Sell | 40% Sell | 24% Buy | ||
| Previous Opinion | 56% Sell | 24% Sell | 48% Buy | ||
| Last Month's Opinion | 56% Buy | 80% Buy | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.99% since 03/20/26 | -1.36% since 03/20/26 | -0.60% since 03/20/26 | ||
| Low | 24.76 on 03/27/26 | 264.97 on 03/27/26 | 118.19 on 03/24/26 | ||
| High | 27.63 on 03/25/26 | 272.71 on 03/23/26 | 125.64 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | -16.58% since 02/27/26 | -10.20% since 02/27/26 | -6.11% since 02/27/26 | ||
| Low | 24.76 on 03/27/26 | 264.97 on 03/27/26 | 118.19 on 03/24/26 | ||
| High | 30.01 on 03/02/26 | 294.47 on 03/02/26 | 129.11 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | -15.71% since 12/26/25 | -8.72% since 12/26/25 | -4.31% since 12/26/25 | ||
| Low | 24.76 on 03/27/26 | 264.97 on 03/27/26 | 118.19 on 03/24/26 | ||
| High | 34.39 on 01/22/26 | 298.61 on 01/07/26 | 132.09 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | -7.06% since 09/26/25 | +4.80% since 09/26/25 | +22.09% since 09/26/25 | ||
| Low | 24.76 on 03/27/26 | 251.90 on 09/29/25 | 98.01 on 09/29/25 | ||
| High | 34.39 on 01/22/26 | 298.61 on 01/07/26 | 132.09 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,027,911 | 15,966,710 | 7,991,003 | ||
| Shares Outstanding, K | 41,100 | 60,170 | 66,820 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | 0 | 0 | 0 | ||
| Last Quarter Sales | N/A | N/A | N/A | ||
| Last Quarter Net Income | N/A | N/A | N/A | ||
| 60-Month Beta | 1.70 | 0.67 | 0.93 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | N/A | ||
| Latest Earnings Date | N/A | N/A | N/A | ||
| Most Recent Dividend | 0.382 on 12/29/21 | 0.994 on 03/24/26 | 0.407 on 12/22/25 | ||
| Next Ex-Dividends Date | 12/29/21 | 03/24/26 | 12/22/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 24.40 | 16.40 | ||